Efficacy, Safety and Pharmacokinetics of QAV680 in Asthma Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

October 31, 2009

Conditions
Asthma
Interventions
DRUG

QAV680

DRUG

Matching placebo for QAV680

DRUG

Fluticasone Propionate

Trial Locations (7)

Unknown

Novartis Investigative Site, Berlin

Novartis Investigative Site, Munich

Novartis Investigative Site, Wiesbaden

Novartis Investigative Site, Ahmedabad

Novartis Investigative Site, Mumbai

Novartis Investigative Site, Mysore

Novartis Investigative SIte, Nagpur

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novartis

INDUSTRY